EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers

Clinical trial NCT05176665 · RECRUITING

Trial details

NCT number: NCT05176665
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis Metastatic Gastrointestinal Carcinoid Tumor

Start date: 2021-10-21
Primary completion: 2025-12-31
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.